SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Jackie Robinson

PatientJackie Robinson
Date of birth1974-01-31
IdentifiersMRN HR-ML037-SYN; SSN (made up) 000-37-2286
Document date2026-07-27
AuthorMarcus Delacroix-Hale, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Visit for blurred vision and new floaters, chest tightness on stairs, calf pain on walking and numb feet, in a man with long-standing diabetes six weeks after the death of his son [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
about 1957Diabetes diagnosed at about 37, around his retirement from baseballD (CLM-0005)
by 1969Nerve and artery damage in both legsD (CLM-0006)
1970Two mild strokesD (CLM-0007)

Family History

RelativeConditionAge at deathEvidence
brotherTwo of his brothers had diabetesD (CLM-0005)
natural sonHis eldest son died in an automobile accident at 2424D (CLM-0011)

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1,000 mg oral tablet, one tablet twice daily with mealsOne tablet twice daily with mealsOral route2025-03-03activeS
Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70At bedtime, by the gradual titration planSubcutaneous route2025-03-03activeS
Lisinopril 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2025-03-03 to 2026-07-29completedS
Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake)One tablet dailyOral route2026-07-27activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route2025-03-03activeS
Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutesAs needed for severe low blood sugarNasal route2026-07-27activeS

Review of Systems

Positive for the concerns in the history of present illness. Alert, direct and composed; grief evident when speaking of his son; no thoughts of self-harm; PHQ-9 score 9. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. Independent in daily activities; cannot read print or drive safely with his present vision; walks about one block before calf pain stops him. [S]

Physical Exam

Vital signs recorded on 2026-07-27; see the Vital Signs section. Mental status: Alert, direct and composed; grief evident when speaking of his son; no thoughts of self-harm; PHQ-9 score 9. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-07-27Body height180cmS
2026-07-27Body weight104kgS
2026-07-27Body mass index (BMI) [Ratio]32.1kg/m2S
2026-07-27Systolic blood pressure152mm[Hg]S
2026-07-27Diastolic blood pressure92mm[Hg]S
2026-07-27Heart rate84/minS
2026-07-27Respiratory rate16/minS
2026-07-27Body temperature36.7CelS
2026-07-27Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-27Hemoglobin A1c/Hemoglobin.total in Blood10.4%Below 5.7% is normal; his first goal below 8%, then below 7%, lowered graduallyHighS
2026-07-27Glucose [Mass/volume] in Serum or Plasma248mg/dL70-139 mg/dLHighS
2026-07-27Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2026-07-27Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-07-27Creatinine [Mass/volume] in Serum or Plasma1.12mg/dL0.74-1.35 mg/dLNormalS
2026-07-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M79mL/min/{1.73_m2}90 or higher is normal; 60 to 89 is mildly decreased (G2)LowS
2026-07-27Albumin/Creatinine [Mass Ratio] in Urine86mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2)HighS
2026-07-27Cholesterol [Mass/volume] in Serum or Plasma226mg/dL<=199 mg/dLHighS
2026-07-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation142mg/dLGoal below 55 mg/dL with atherosclerotic diseaseHighS
2026-07-27Cholesterol in HDL [Mass/volume] in Serum or Plasma38mg/dL>=40 mg/dLLowS
2026-07-27Triglyceride [Mass/volume] in Serum or Plasma230mg/dL<=149 mg/dLHighS
2026-07-27Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-55 U/LNormalS
2026-07-27Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L8-48 U/LNormalS
2026-07-27Hemoglobin [Mass/volume] in Blood13.9g/dL13.5-17.5 g/dLNormalS
2026-07-27Platelets [#/volume] in Blood by Automated count25010*3/uL150-400 10*3/uLNormalS
2026-07-27Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma380pg/mL232-1245 pg/mLNormalS
2026-07-27Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.4-4.5 mIU/LNormalS
2026-07-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S

Problems

ProblemClinical statusVerificationCodeProvenance
Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arrangedactiveconfirmed H53.8S — Synthetic presenting finding, superseded by the retinal diagnosis two days later.
Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arrangedactiveconfirmed R07.89S — Synthetic presenting finding, superseded by the coronary diagnosis after the stress test.
Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%)activeconfirmed E11.65S — Synthetic modern episode linked to his documented diabetes.
Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg)activeconfirmed I12.9S — Synthetic modern episode linked to his documented high blood pressure.
Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79activeconfirmed E11.22S — Synthetic kidney findings.
Chronic kidney disease G2 A2activeconfirmed N18.2S — Synthetic kidney finding.
Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulsesactiveconfirmed E11.51S — Synthetic modern episode linked to the documented artery damage in his legs.
Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testingactiveconfirmed E11.42S — Synthetic modern episode linked to the documented nerve damage in his legs.
History of two mild strokes a year ago, without lasting weaknessactiveconfirmed Z86.73S — Synthetic modern coding of the documented strokes.
Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dLactiveconfirmed E78.5S — Synthetic laboratory finding.
Bereavement: his eldest son died in a car crash six weeks agoactiveconfirmed Z63.4S — Synthetic modern coding of a documented loss; grief is treated as grief, not as a disorder.

Assessment

Plan of Treatment